Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1)
Related Experiment Video
Updated: Sep 28, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Masataka Sugimoto1, Nicholas Martin, Deepti P Wilks
1Cancer Research UK, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, UK.
Abstract:
Deregulation of D-type cyclin-dependent kinases (CDK4 and 6) is widely observed in various human cancers, illustrating their importance in cell cycle control. Like other cyclin-dependent kinases (CDKs), assembly with cyclins is the most critical step for activation of CDK4/6. As previously reported elsewhere, we observed that the level of cyclinD1-CDK4 complex and its associated kinase activity were significantly low in asynchronously proliferating mouse embryo fibroblasts lacking both p21(Cip1) and p27(Kip1) (p21/p27-null MEFs). These evidences imply that p21(Cip1) and p27(Kip1) CDK inhibitors are 'essential activators' of cyclin D-kinases. We, however, discovered here that both the assembly and activation of cyclin D1-CDK4 complex occur when quiescent p21/p27-null MEFs were stimulated to re-enter the cell cycle. This mitogen-induced cyclin D1-kinase activity was blocked by overexpression of p16(INK4a) and resulted in the inhibition of S phase entry in p21/p27-null MEFs. Furthermore, ectopic expression of p34(SEI-1), a mitogen-induced CDK4 binding protein, increased the levels of active cyclinD1-CDK4 complex in asynchronously proliferating p21/p27-null MEFs. Together, our results suggest that there are several independent ways to stimulate the assembly of cyclin D1-CDK4 kinases. Although p21(Cip1) and p27(Kip1) play a role in this process, our results demonstrate that additional mechanisms must occur in G0 to S phase transition.
Insights
p21(Cip1) and p27(Kip1) are not essential activators for cyclin D-CDK4/6 kinase assembly. Instead, multiple mechanisms regulate this process, particularly during cell cycle re-entry from quiescence.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cyclin-dependent kinases (CDKs) like CDK4 and CDK6 are crucial for cell cycle control and are frequently deregulated in cancers.
- Activation of CDK4/6 requires assembly with D-type cyclins.
- CDK inhibitors p21(Cip1) and p27(Kip1) were previously thought to be essential for cyclin D-CDK4/6 activation.
Purpose of the Study:
- To investigate the role of p21(Cip1) and p27(Kip1) in the assembly and activation of the cyclin D1-CDK4 complex.
- To identify alternative mechanisms regulating cyclin D1-CDK4 kinase activity.
- To understand the regulation of cell cycle re-entry in the absence of p21(Cip1) and p27(Kip1).
Main Methods:
- Utilized mouse embryo fibroblasts (MEFs) lacking both p21(Cip1) and p27(Kip1) (p21/p27-null MEFs).
- Stimulated quiescent p21/p27-null MEFs to re-enter the cell cycle.
- Assessed cyclin D1-CDK4 complex assembly and kinase activity.
- Investigated the effects of p16(INK4a) overexpression and p34(SEI-1) ectopic expression.
Main Results:
- Cyclin D1-CDK4 complex assembly and activation occur in quiescent p21/p27-null MEFs upon mitogen stimulation.
- Mitogen-induced kinase activity is inhibited by p16(INK4a) overexpression, blocking S phase entry.
- Ectopic expression of p34(SEI-1) enhances active cyclin D1-CDK4 complex levels in asynchronously proliferating cells.
Conclusions:
- p21(Cip1) and p27(Kip1) are not essential activators for cyclin D1-CDK4 kinase assembly.
- Multiple independent mechanisms can stimulate cyclin D1-CDK4 kinase assembly.
- Additional regulatory mechanisms beyond p21/p27 function are critical for G0 to S phase transition.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex
Mitogens and the Cell Cycle

